Skip to main content
Caplight Logo









AcroViz

AcroViz

Private
Taipei CityHealthcare & Life Scienceshttps://acroviz.com/

Last Round

Accelerator

Apr 21, 2022

Company Overview

AcroViz is a health care company that develops imaging biomarkers designed to analyze brain health using neural fiber imaging and machine learning to predict the risk and prognosis of dementia.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Medical Devices, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

brain agedementia risk predictiondiffusion MRIdMRImedical AIimaging biomarkersbrain health assessmentmedical imagingpredictive diagnosticsneuroimaging AImedical device softwareAI dementia diagnosisAlzheimer's predictionbrain scan analysisFDA 510(k) clearanceprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AcroViz Comparables

Compare AcroViz with similar companies based on industry and business-model similarity.

AcroViz comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Darmiyan
82%
DeepRad AI
80%
NeuroAge Therapeutics
78%

AcroViz Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 21, 2022

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 86% MoM, reaching 6.4K.

  • Jan 2, 2026

    Monthly visitors increased 35% MoM, from 4.8K to 6.5K.

AcroViz Filings

Explore SEC and related filing metadata, where available.

AcroViz filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AcroViz's valuation, stock price, and market status.

Is AcroViz a public or private company?

AcroViz is a private company.

What is the current stock price of AcroViz?

AcroViz is a private company with no public stock price. No recent secondary market data is available.

How much is AcroViz worth (valuation)?

Valuation information for AcroViz is not publicly available.

Can I buy AcroViz stock?

AcroViz shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AcroViz's last funding round?

Funding round information for AcroViz is not publicly available.

Who are the main investors in AcroViz?

Investor information for AcroViz is not publicly disclosed.

Will AcroViz IPO soon?

No public IPO plans have been announced for AcroViz.

How can I track AcroViz secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AcroViz's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTaipei City
Employee Range2
Year Founded2017
Last FundingApr 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?